LSII - Trademark Details
Status: 686 - Published For Opposition
Image for trademark with serial number 88739792
Serial Number
88739792
Word Mark
LSII
Status
686 - Published For Opposition
Status Date
2022-01-28
Filing Date
2019-12-26
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
090104, 261901 - Ribbons, bows. Spheres.
Published for Opposition Date
2021-09-14
Attorney Name
Danielle I. Mattessich
Law Office Assigned Location Code
O20
Employee Name
HENRY, NAKIA D
Statements
Indication of Colors claimed
The color(s) white, blue, navy blue, gray, and red is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a hollow sphere design in color outlined by brush-strokes, which looks like a white-colored sphere wrapped by colorful ribbons. The upper part of the sphere has a blue stroke, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stroke. There is a red line that streaks across the center of the sphere from the top to the bottom. The light blue ribbon does not touch the dark blue ribbon. The space in between is void of color. Stylized and capitalized word" LSII" in gray is shown on the right side of the sphere design.
Goods and Services
Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-01-04
Primary Code
005
Current Trademark Owners
Party Name
Life Science Institute, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Life Science Institute, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Life Science Institute, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Danielle I. Mattessich
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2019-12-242019-165750JapanTrue
Trademark Events
Event DateEvent Description
2019-12-30NEW APPLICATION ENTERED IN TRAM
2020-01-04NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-01-07NOTICE OF DESIGN SEARCH CODE E-MAILED
2020-03-20ASSIGNED TO EXAMINER
2020-03-24NON-FINAL ACTION WRITTEN
2020-03-24NON-FINAL ACTION E-MAILED
2020-03-24NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-06-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-06-17ASSIGNED TO LIE
2020-06-17CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-06-17TEAS/EMAIL CORRESPONDENCE ENTERED
2020-06-19SUSPENSION LETTER WRITTEN
2020-06-19LETTER OF SUSPENSION E-MAILED
2020-06-19NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2021-01-11SUSPENSION LETTER WRITTEN
2021-01-11LETTER OF SUSPENSION E-MAILED
2021-01-11NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2021-02-19TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2021-02-27CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-02-27TEAS/EMAIL CORRESPONDENCE ENTERED
2021-03-22NON-FINAL ACTION WRITTEN
2021-03-22NON-FINAL ACTION E-MAILED
2021-03-22NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-07-14TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-07-14CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-07-14TEAS/EMAIL CORRESPONDENCE ENTERED
2021-08-10APPROVED FOR PUB - PRINCIPAL REGISTER
2021-08-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-08-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-08-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-09-14PUBLISHED FOR OPPOSITION
2021-09-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-09-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-09-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-11-09NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-11-29TEAS DELETE 1(B) BASIS RECEIVED
2021-12-17TEAS DELETE 1(B) BASIS RECEIVED
2022-01-28CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-12-17NOTICE OF ALLOWANCE CANCELLED
2022-01-281(B) BASIS DELETED; PROCEED TO REGISTRATION